A first-of-its-kind cancer treatment
BXQ-350 is a first-of-its-kind cancer treatment that weaponizes the special mechanics of cancer to destroy it. Discovered by Xiaoyang Qi - Professor of Medicine, Co-Division Chief for Basic Science Research - BXQ-350 is a protein which can fuse to the walls of cancerous cells, causing those cells to die off.
The innovative drug is made from a human protein and does something unlike any other: It weaponizes the special mechanics of cancer to destroy it, without affecting healthy cells.
Qi reported that the treatment packed a one-two punch. First, BXQ-350 gets into a cellular trash compactor called the lysosome and stuffs it until the structure rips open. Second, BXQ-350 makes a cancerous cell pay attention again to the natural signal to die.”